Cell Biology of Ureter Development by Woolf, Adrian S. & Davies, Jamie A.
  
 
 
 
Edinburgh Research Explorer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cell Biology of Ureter Development
Citation for published version:
Woolf, AS & Davies, JA 2013, 'Cell Biology of Ureter Development' Journal of the American Society of
Nephrology, vol 24, no. 1, pp. 19-25. DOI: 10.1681/ASN.2012020127
Digital Object Identifier (DOI):
10.1681/ASN.2012020127
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:
Peer reviewed version
Published In:
Journal of the American Society of Nephrology
Publisher Rights Statement:
''(...) authors are encouraged
to archive their version of the manuscript in their institution’s
repositories (aswell as on their personalwebsites).Authors should cite
the publication reference and doi number on any deposited version,
and provide a link fromit to the published article on the JASNwebsite.''
http://jasn.asnjournals.org/site/misc/ifora.xhtml
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 28. Apr. 2017
Invited Brief Review for J Am Soc Nephrol 
Cell biology of ureter development 
1Adrian S. Woolf and 2Jamie A. Davies 
1School of Biomedicine, University of Manchester, Manchester Academic Health Science Centre 
and Manchester Children’s Hospital, Manchester M13 9PT, UK and 2Centre for Integrative 
Physiology, Hugh Robson Building, University of Edinburgh, Edinburgh EH8 9XD, UK. 
Addresses for correspondence: 
Adrian S. Woolf, Michael Smith Building, University of Manchester, Oxford Road, Manchester, 
M13 9PT, UK. Email adrian.woolf@manchester.ac.uk  
Jamie A. Davies, Centre for Integrative Physiology, Hugh Robson Building, University of 
Edinburgh, Edinburgh EH8 9XD, UK Email jamie.davies@ed.ac.uk 
Acknowledgements 
A.S.W. acknowledges grant support from: Kidney Research UK, Kids Kidney Research, Kidneys 
for Life, the Manchester NIHR Biomedical Research Centre and the Wellcome Trust. J.A.D 
acknowledges grant support from the National Centre for 3Rs, the Biotechnology and Biological 
Sciences Research Council, the National Institutes of Health (NIDDK) and the Wellcome Trust. 
Conflict of interest 
None declared 
Abstract  
The mammalian ureter contains two main cell types: a multilayered water-tight epithelium called 
the urothelium, surrounded by smooth muscle layers which, by generating proximal to distal 
peristaltic waves, pump urine from the renal pelvis toward the urinary bladder. Here, we review 
the cellular mechanisms involved in the development of these tissues, and the molecules which 
control these processes. We consider the relevance of these biological findings for 
understanding the pathogenesis of human ureter malformations. 
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ALK Activin receptor-like kinase (growth factor receptor) 
AngII Angiotensin II (growth factor) 
BMP Bone morphogenetic protein (growth factor) 
DLGH Discs-large homolog (intracellular scaffolding protein) 
ERK Extracellular signal-regulated kinase (intracellular signaling molecule) 
ETV ETS transcription factor (transcription factor) 
FGFR Fibroblast growth factor receptor (growth factor receptor) 
FOX Forkhead box (transcription factor) 
FRAS Fraser syndrome (basement membrane molecule) 
FREM FRAS1-related extracellular matrix (basement membrane molecule) 
GDNF Glial cell line-derived neurotrophic factor (growth factor) 
GATA GATA-binding factor (transcription factor) 
GFR GDNF family receptor (growth factor receptor) 
HCN3 Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 3 (ion 
channel) 
HNF1B Hepatocyte nuclear factor 1B (transcription factor) 
KIT v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog (growth factor receptor) 
MYOCD (transcription factor associated protein) 
PAX Paired box (transcription factor) 
PI3K Phosphatidylinositol 3-kinase (intracellular signaling molecule) 
PLC Phospholipase C (intracellular signaling molecule) 
PTCH Patched (growth factor receptor) 
RET Rearranged during transfection (growth factor receptor) 
ROBO Roundabout (growth factor receptor) 
ROCK Rho-associated protein kinase (intracellular signaling molecule) 
SMAD Homologs of drosophila protein, mothers against decapentaplegic and Caenorhabditis 
elegans protein SMA (intracellular signaling molecule) 
SHH Sonic hedgehog (growth factor) 
SLIT Slit homolog (growth factor) 
SOX SRY-related HMG-box (transcription factor) 
TBX T-box (transcription factor) 
TGF Transforming growth factor (growth factor) 
TSHZ Teashirt (transcription factor) 
UPK Uroplakin (urothelial membrane protein) 
VANGL Van gogh-like (planar cell polarity protein) 
 
Initiation of the ureteric epithelium 
(see Molecule Abbreviation Box) 
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The nephric (or Wolffian) ducts (NDs) are a pair of epithelial tubes, each of which runs along the 
intermediate mesoderm. Each ND gives rise to a ureteric precursor, the ureteric bud (UB), which 
grows into metanephric mesenchyme (MM) cells condensing out of intermediate mesoderm. 
Normally, a single bud emerges from each ND near its distal (caudal) end, a precision facilitating 
optimal interactions between UB and MM which are required to generate a single ureter-kidney 
functional unit, of normal shape and internal structure (Mackie and Stephens 1975; Kume et al 
2000; Ichikawa et al 2002). In principle, normal budding could be controlled either by pre-
patterning within the duct itself or by external signals. Experiments with explanted NDs provide 
no evidence for a strong intrinsic pre-pattern. Instead, any part of the duct, even the more 
proximal (cranial) section lying alongside the mesonephric kidney, can be stimulated to emit 
ectopic UBs by applying certain molecules (Sainio et al 1997; Davies et al 1999; Maeshima et al 
2006) the actions of which can be understood by considering intracellular pathways under their 
control (Davies 2002) (Figure 1).  
 
 
 
Figure 1. Intracellular pathways modulating UB emergence from the ND.  
Pathways that encourage (green) and pathways that inhibit (red) bud emergence are depicted. (see also 
Molecule Abbreviation Box) 
 
UB emergence is antagonized by SMAD signaling but favored by ERK, PI3K and PLC activation 
(Costantini 2010). NDs express activin A which acts in an autocrine manner to activate SMADs 
and prevent budding (Maeshima et al 2006). However, when an isolated ND is treated with both 
an activin antagonist and a growth factor that activates ERK, PI3K and PLC pathways, multiple 
buds emerge along its length (Maeshima et al 2006). In such experiments, numerous normal 
diameter buds rather than one large cyst are generated, implying a yet-be-be defined lateral 
inhibition mechanism whereby bud tip cells direct their immediately-neighbors to remain 
quiescent.  
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ND cells express various cell surface receptors, each of which binds pro- or anti-branching 
factors. RET and FGFR2 receptor tyrosine kinases, and their GFRα and sulphated 
glycosaminoglycan co-receptors, bind GDNF and FGFs, activating ERK, PI3K and PLC 
pathways and driving UB emergence (van Weering 1998; Eswarakumar et al 2005). Expression 
of such receptors depends on duct cells expressing the GATA3 transcription factor (Grote et al 
2008), and β-catenin, a multifunctional intracellular protein, (Marose et al 2008; Michos 2009), 
and on nearby stromal cells synthesizing retinoic acid, an effector metabolite of vitamin A 
(Rosselot et al 2010). The extent of intracellular signaling triggered by receptor tyrosine kinases 
is limited by the cytoplasmic protein sprouty-1, without which the ND produces multiple ectopic 
buds (Basson et al 2005). Additionally, signaling between SLIT2 and ROBO2 (Grieshammer et 
al 2004; Lu et al 2007), members of molecular families first implicated in neural guidance, 
together with expression of FOXC1 transcription factor (Kume et al 2000), guard against UB 
ectopia by limiting the cranial extent of the GDNF expression domain within intermediate 
mesoderm. As alluded to above, bud emergence is also antagonized by TGFβ family members 
(e.g. activins and BMPs), autocrine and paracrine factors which bind ALK receptor threonine 
kinases, activating the SMAD pathway (Michos et al 2007). Normally, in vivo, SMAD activation is 
favored along most of the ND (Bush et al 2004). By contrast, near the duct’s caudal end, MM 
secretes the BMP antagonist Gremlin-1 (Michos et al 2007) and the RET agonist GDNF and 
these, together with ANGII-mediated Sprouty-1 downregulation (Yosypiv et al 2006 and 2008), 
favor formation of a solitary, correctly-placed UB (Figure 2). An autocrine loop involving 
neuropeptide Y may enhance the commitment of these ND cells to budding (Choi et al 2009).  
 
 
 
 
Figure 2. Growth factors controlling UB emergence from the ND.  
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The caudal part of the embryo, with the cloaca/urogenital sinus, is on the left of the diagram. Except near 
the MM, inhibitory signals such as BMP4 and activin dominate the molecular landscape. MM produces 
activators such as GDNF in addition to gremlin-1 (Grem1) and follistatin which respectively antagonize the 
anti-branching factors BMP4 and activin. At this precise point, the balance between activation and 
inhibition favors emergence of a single UB. (see also Molecule Abbreviation Box) 
 
 
ND budding is preceded by increased epithelial proliferation (Michael and Davies 2004) and 
thickening to a pseudostratified epithelium (Chi et al 2009). RET signaling leads to 
rearrangement of ND cells such that those with the greatest ERK/PI3K/PLC activation move 
together and produce the bud (Kuure et al 2010a). This movement is also modulated by ETV4 
and ETV5, transcription factors upregulated by GDNF/RET signaling (Kuure et al 2010a). During 
UB branching, epithelial cells become wedge-shaped, implicating cytoskeletal changes involving 
actin microfilaments. Indeed, mutation of genes coding for the actin depolymerizing factors 
cofilin 1 and destrin affect branching (Kuure et al 2010b), as does inhibition of ROCK, a 
molecule driving actin rearrangements (Michael et al 2005; Meyer et al 2006). ROCK is itself 
modulated by the planar cell polarity protein VANGL2 (Yates et al 2010). In vitro, UB epithelia 
undergo apoptotic death if physically separated from MM, and mesenchymal-derived factors 
such as GDNF may facilitate UB survival as well as emergence (Towers et al 1998). The PAX2 
transcription factor is normally expressed in the ND and the emerging bud and is anti-apoptotic 
in the UB/collecting duct lineage (Torban et al 2000; Dziarmaga et al 2006). Prominent ND/UB 
apoptosis and impaired UB formation occurs in embryos lacking HNF1B (also known as vHNF) 
(Lokmane et al 2010). This transcription factor is normally expressed in the ND/UB where it may 
directly upregulate PAX2 (Lokmane et al 2010). 
 
What happens to the top and bottom of the bud? 
 
Once the UB’s enters the MM, it begins to branch to produce kidney collecting ducts. 
Consideration of these events is beyond the remit of the current review and has been covered 
elsewhere (Davies & Fisher 2002; Michos 2009). It is unclear how similar are the mechanisms of 
UB emergence to its subsequent arborisation. Interestingly, the UB’s proximal-distal axis does 
not initially restrict the branching ability of its cells because, experimentally, a collecting duct tree 
can be generated from either end of the nascent ureter (Sweeney et al 2008).  
 
The just-formed ureter is separated from the urogenital sinus, the bladder precursor, by a length 
of ND extending beyond the point of UB emergence (Chia et al 2011). When development is 
complete, however, the ureter connects directly to the bladder, an anatomical change requiring 
substantial remodeling. Previous teaching postulated that the caudal-most ND cells migrated 
into the base of the bladder where they formed the urothelium of the trigone, the triangular zone 
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between the ureteric orifices and the urethral outlet of the bladder; as this occurred, the 
ureter/ND junction would approximate to the bladder wall. Lineage tracing of genetically-labeled 
ND cells shows that the first part of this model is incorrect (Mendelsohn 2009). In fact, the 
caudal-most part of the ND involutes by apoptosis induced by signals from the forming bladder 
(Batourina et al 2005). The vesicoureteric junction then becomes physically separated from the 
opening of the ND, maintained in males as the ejaculatory duct, as they are pushed apart by 
growth of the bladder wall.   
 
Further growth and differentiation of ureteric epithelia 
 
The shaft of the UB, between the kidney and the ND, grows and differentiates to become the 
mature ureter. In contrast to UB initiation, less is known about the cell biology of ureteric growth. 
Once emerged, the bud runs straight to the MM but the guidance mechanisms are not 
understood. When extra UBs are induced with beads soaked in stimulatory growth factors, they 
do not always grow towards the beads (Davies et al 1999), arguing against simple chemotaxis. 
Initial extension of the emerging UB depends on its epithelia expressing FRAS1 (McGregor et al 
2003). This basement membrane protein acts in a complex with two related molecules, FREM1 
and FREM2, probably optimizing presentation of MM-derived growth factors to the bud (Pitera et 
al 2008) and also physically stabilizing UB/MM interactions by binding integrin α8 (Kiyozumi et al 
2005). A similar lack of UB progression occurs in mutant mice lacking this matrix receptor which 
is normally expressed on the surfaces of MM cells (Muller et al 1997).  
 
As it extends, the bud becomes thinner than the zone of ND that produced it, suggesting cell 
rearrangements involving convergent extension, which is known to drive the remarkable 
longitudinal growth of Malpighian kidney tubules in fly embryos (Jung et al 2005). Ureters are 
shorter than normal in TBX18 null mutant mice (Airik et al 2006). This transcription factor is 
normally expressed in mesenchymal cells surrounding the urothelial stalk and its absence is 
associated with decreased epithelial proliferation (Airik et al 2006). Once initiated, further 
longitudinal growth occurs in isolated wild-type embryonic ureters maintained in organ culture 
(Caubit et al 2008) and in ureters of certain mutant embryos lacking kidneys (Bush et al 2006). 
Both observations show that exposure to fetal urine is not needed for longitudinal growth, 
although these experiments do not rule out a more subtle, differentiation-optimizing influence 
conferred by urine flow which, in mice, probably begins several days after UB initiation when the 
metanephros has formed its first layers of vascularized glomeruli (Figure 3).  
 
Urothelia in both the ureter and bladder have evolved to stop movement of urine back into the 
body. Prevention of movement of water and solutes through the apical-most epithelial layer is 
mediated by plaques made of UPK protein heterodimers (Jenkins and Woolf 2007; Wu et al 
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2009). UPK expression occurs early in urinary tract development, being present in epithelia 
lining the urogenital sinus (Jenkins 2005 and 2007). In mutant mice lacking either UPK3A or 
UPK2 proteins, plaques are disorganized and urothelia are leaky. These animals also have 
malformed urinary tracts with gaping (instead of normal slit-like) vesicoureteric junctions, and 
dilated ureters associated with either reflux of urine from the bladder or occlusion by exuberant 
urothelial growth (Hi et al 2000; Kong et al 2004). These structural anomalies might simply be 
secondary disruptions following on from loss of the urothelial physical barrier. It has, however, 
been postulated (Jenkins and Woolf 2007) that they may also result from perturbed intracellular 
signaling by analogy with the proven role for uroplakin proteins in triggering embryogenesis in 
frog eggs. UPK expression is compromised in ureters of mouse embryos engineered to have 
downregulated BMP4 (Brenner-Anantharam et al 2007) or TBX18 (Airik et al 2006), both 
proteins being normally expressed in adjacent SM precursor cells. Furthermore, application of 
BMP4 to explanted metanephroi induces UPK expression in ureteric bud branch tips within the 
organ (Brenner-Anantharam et al 2007), suggesting that these UB descendants can be 
reprogrammed into a urothelial fate.  
 
Ureteric muscle formation and function 
 
The shaft of the embryonic ureter initially comprises an epithelial tube extending through loose 
mesenchyme. This epithelium acts as a paracrine signaling centre, driving surrounding cells to 
differentiate into SM (Lye et al 2010). The urothelium secretes SHH, a growth factor that binds 
to the PTCH1 receptor in immediately adjacent mesenchymal cells, stimulating them to 
proliferate (Yu et al 2002). Peri-urothelial mesenchymal cells are also stimulated to express 
BMP4 which itself effects their own differentiation into SM (Yu et al 2002; Brenner-Anantharam 
et al 2007). Here, BMP4 enhances intracellular levels of phospho-SMADs (Caubit et al 2008; 
Wang et al 2009) and upregulates TSHZ3, a transcription factor-like protein. TSHZ3 is needed 
for MYOCD expression within nascent ureteric SM cells. MYOCD is transcriptional co-activator 
then upregulates genes coding for muscle contractile proteins, such as a smooth muscle actin 
and myosin heavy chains (Caubit el al 2008; Lye et al 2010). Lack of another transcription 
factor, SOX9, which is, like TSHZ3, is normally expressed by mesenchyme aggregating around 
the urothelial ureteric tube, also leads to failed SM differentiation (Airik et al 2010). The 
aggregation of SM precursor cells around urothelia depends on mesenchymal expression of 
TBX18; in mice engineered to lack this transcription factor prospective SM precursors become 
mislocalized to the surface of the metanephric kidney (Airik et al 2006). Correct orientation of 
ureteric SM cells depends on DLGH1, an intracellular scaffolding protein highly expressed in 
urothelia and more weakly in nascent SM cells (Mahoney et al 2006). When DLGH1 is 
inactivated, circular muscle bundles misalign in a longitudinal orientation. In mutant embryos 
lacking this protein, the differentiation of stromal cells between the urothelium and SM layer is 
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perturbed, suggesting that stroma may somehow control SM bundle alignment. Cell lineage 
experiments have shown that ureteric SM is distinct from muscle layers in the wall of the urinary 
bladder (Viana et al 2007). After the shaft of the ureter has become enveloped with SM, there 
appears to be a secondary wave of muscle differentiation at the proximal end (top) of the ureter 
where it merges into the renal pelvis. These events are mediated by the protein phophatase 
calcineurin (Chang et al 2004) and by ANGII signaling (Miyazaki et al 1998). Mice that are 
genetically engineered to lack key molecules in the ureteric SM-differentiation pathway have the 
common phenotype of hyroureter/hydronephrosis. The dilation arises not from anatomical 
obstruction but because of a back-up of urine in a functionally-obstructed tube lacking normal 
peristaltic waves.  
 
Forming a network within the SM layers are neural-like, KIT receptor tyrosine kinase-expressing 
cells that are required for generation of contraction waves beginning before birth (David et al 
2005). Notably, the explanted fetal ureter, even when physically disconnected from the kidney 
and bladder, undergoes regular peristalsis in a proximal to distal direction (Caubit et al 2008). In 
vivo, peristalsis is triggered by HCN3, a hyperpolarization-activated cation channel expressed in 
the renal pelvis/kidney junction (Hurtado et al 2010). When hedgehog signaling is experimentally 
downregulated in this region, expression of KIT and HCN3 are compromised and contractions 
are perturbed, even though SM cells themselves appear intact (Cain et al 2011). The mature 
ureter also contains adrenergic, cholinergic, nitrergic, and sensory nerves (Rolle et al 2008), the 
activities of which modify its contractility (Canda et al 2007).  
 
A theoretical scheme, in which the onset of fetal urine production by the kidney enhances 
ureteric SM differentiation and function, is depicted in Figure 3. 
 
HARMONISED FUNCTIONAL 
DEVELOPMENT OF THE KIDNEY 
AND URETERIC
Onset of urine production by fetal kidney
▼
Uroplakins sense a (yet-to-be defined) 
component of fetal urine 
▼
Urothelia differentiate and establish 
a paracrine signalling centre
▼
Urothelial growth factors
induce adjacent smooth muscle
▼
Ureteric peristalsis propels urine to the bladder  
 
Figure 3. Harmonised kidney and ureteric functional development 
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Implications for understanding human congenital ureter malformations 
 
The human ureter can be affected by several types of malformation (Williams et al 2008; 
Kerecuk et al 2008; Lye et al 2010), the. The most severe, and rarest (about 0.01-0.1% births), 
is its unilateral or bilateral absence, characteristically accompanied by kidney agenesis (Welch 
1958). Ureteric dilation associated with ureteropelvic junction obstruction or primary megaureter 
affects up to 0.2% births (reviewed in Lye et al 2010). Even more common is ureteric duplication 
(2% of the population); in its most severe form the kidney is also “duplex”, with the top part 
connected to an obstructed ureter with an ectopic termination in the urethra or vas deferens, and 
the bottom part connected to a refluxing ureter which inserts too laterally in the bladder wall 
(Mackie and Stephens 1975). Vescioureteric reflux affects at least 0.5% of births, with some 
estimates of incidence an order of magnitude higher (Williams et al 2008). Sometimes these 
malformations occur as part of a syndrome affecting other parts of the body (see Online 
Mendelian Inheritance in Man), while at other times, the renal lesions occur in isolation.  
 
A knowledge of how specific molecules controling ureter development help us understand why 
mutations of certain genes cause human disease. Fraser syndrome often features bilateral 
ureter and renal agenesis and can be caused by biallelic mutations of either FRAS1 or FREM2, 
each encoding a UB basement membrane protein (McGregor et al 2003; Jadeja et al 2005). 
Furthermore, mutations of RET have been implicated in humans with similarly severe renal tract 
malformations (Skinner et al 2008). Mutations in ROBO2 have been reported in individuals born 
with refluxing and/or duplicated ureters (Lu et al 2007). Congenitally-dilated ureters can occur in 
humans who have mutations of SOX9 (in Campomelic dysplasia) or GLI3 (Pallister-Hall 
syndrome), encoding a transcription factor involved in SHH signaling. By analogy with the 
mouse models described earlier, one may postulate that such ureters may be functionally-
obstructed because of poorly formed an/or poorly functioning MS bundles. In the uro-facial 
syndrome, dilated ureters occur together with vesicoureteric reflux and dysfunctional urinary 
tract contractions (Daly et al 2010). These individuals have mutations of HPSE2, the gene 
coding for heparanase-2, an endogenous inhibitor of classical heparanse (Levy-Adam et al 
2010). Both molecules are expressed in the developing ureter (Daly et al 2010) where they may 
mediate neuro-muscular functional differentiation. UPK3A mutations have been reported in 
humans born with ureteric malformations (Jenkins et al 2005) resembling those described in 
mice genetically engineered to lack the encoded urothelial plaque protein. Genes coding for 
several of other proteins (e.g. PAX2, GATA3, HNF1B) implicated in ureter development have 
been found to be mutated in humans renal tract malformations (Bilous et al 1992; Sanyanusin et 
al 1995; Adalat et al 2009). In some instances, the gene in question is also expressed in, and 
has intrinsic roles in, the kidney itself. Accordingly, the manifest renal malformation may reflect 
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multiple primary aberrations of upper and lower renal tract development. Good examples are 
HNF1B, where human mutations can cause ureteric atresia and cystic dysplastic kidneys 
(Adalat et al 2009), and PAX2, where human mutations are associated with vesicoureteric relfux 
and kidney hypoplasia  (Sanyanusin et al 1995).  
 
Ongoing discovery of novel or unsuspected ureter development genes 
 
The genetic search for new human ureteric malformation genes continues, with numerous loci 
suggested by genome-wise analyses (e.g. Kelly et al 2007; Weng et al 2009; Cordell et al 2010). 
Fortunately for human geneticists, and also those researching the basic mechanisms of renal 
tract development, there is open access to a resource that makes high-throughput analyses of 
gene expression freely available to all. The GenitoUrinary Development Molecular Anatomy 
Project (GUDMAP) database holds information on RNA array analyses from microdissected 
tissues in the developing murine urogenital system (Harding et al 2011). At the time of writing, 
there are also over 1450 in situ hybridization entries showing gene expression in the developing 
ureter. Examples of transcripts which have a with particularly strong and specific ureter 
expression are shown in Table 1. Cross-referencing with OMIM, to ascertain whether any have 
been associated with human disease and/or might fit into what is already known about the 
biology of ureter development, revealed the following points. HOXA1 mutation is associated with 
a brainstem dysgenesis syndrome, although the state of the renal tract was not reported; ISL1 is 
a known activator of BMP4 expression; MNX1/HLXB9 mutations are implicated in  Currarino 
syndrome, characterised by anorectal and sacral malformations and which can sometimes 
feature duplex ureter, hydronephrosis, vesicoureteric reflux; and Nrap encodes a protein 
implicated in achoring of myofibrillar proteins.  
 
Table 1.  
Transcripts with strong and specific ureteric expression in developing mice, as reported 
in the GUDMAP database. 
 
Esrrb (estrogen-related receptor-β) 
Hnf4g hepatocyte nuclear factor 4γ 
Hoxa1 (Homeobox1α) 
Isl1 (Isl LIM homeobox-1) 
Lhx6 (Lim Homeobox gene 6) 
Lix1 (Limb expression 1) 
Mbd1 (Methyl-CpG-binding domain protein 1) 
Neurod4 (Neuorgenic differentiation 4) 
Nrap (Nebulin related anchoring protein) 
Spdef (SAM pointed domain-containing ETS transcription factor) 
Tox3 (Tox high mobility group box family member 3) 
Zfhx4 (Zinc finger homeobox 4) 
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